Congenital human cytomegalovirus (CMV) infection is the leading nongenetic etiology of sensorineural hearing loss (SNHL) at birth and prelingual SNHL not expressed at birth. The paucity of temporal bone autopsy specimens from infants with congenital CMV infection has hindered the critical correlation of histopathology with pathogenesis. Here, we present an in vitro embryonic mouse model of CMV-infected cochleas that mimics the human sites of viral infection and associated pathology. There is a striking dysplasia/hyperplasia in mouse CMV-infected cochlear epithelium and mesenchyme, including organ of Corti hair and supporting cells and stria vascularis. This is concomitant with significant dysregulation of p19, p21, p27, and Pcna gene expression, as well as proliferating cell nuclear antigen (PCNA) protein expression. Other pathologies similar to those arising from known deafness gene mutations include downregulation of KCNQ1 protein expression in the stria vascularis, as well as hypoplastic and dysmorphic melanocytes. Thus, this model provides a relevant and reliable platform within which the detailed cell and molecular biology of CMV-induced deafness may be studied. Birth Defects Research (Part A) 97:69-78, 2013. Ó
INTRODUCTION
Congenital cytomegalovirus (CMV) infection is the leading cause of nongenetic birth defects, variably inducing hearing loss, blindness, and mental retardation Pass et al., 2006; Schleiss and Choo, 2006; Pass, 2007; Schleiss, 2006 Schleiss, , 2008 www.cdc.gov/cmv) . Sensorineural hearing loss (SNHL) is the most frequent sequelae of in utero infection, accounting for 20 to 60% of all SNHLs. It is estimated that at least 8000 infants born annually in the United States will have congenital CMVinduced SNHL, at birth or later in early childhood. In newborns with congenital CMV infection, higher viral load at birth is consistently correlated with the presence of symptoms of congenital CMV and an elevated risk of SNHL; asymptomatic newborns have a lesser elevated risk (Cannon et al., 2011) . Indeed, the cumulative risk of SNHL by age 8 is approximately 34% and 7% for populations of symptomatic and asymptomatic congenital CMVinfected children, respectively (Rosenthal et al., 2009) . Thus, it is now well-established that congenital CMV infection is the major nongenetic cause of SNHL at birth and prelingual SNHL not expressed at birth (Barbi et al., 2003; Fowler and Boppana, 2006; Nance et al., 2006; Schleiss and Choo, 2006; Foulon et al., 2008a; Foulon et al., 2008b; Grosse et al., 2008; Cheeran et al., 2009 ).
Sensorineural hearing is mediated by the organ of Corti and associated structures in the scala media (SM), all of which sits inside the cochlear duct of the inner ear between the scala vestibuli (SV) and scala tympani (ST); the organ of Corti contains inner and outer mechanosensory hair cells embedded in a variety of supporting cells (Fig. 1A-C) . Fluid-borne vibrations create a shearing vector in the stereocilia of the hair cells and subsequent signaling to the auditory cortex via the spiral ganglion and cochlear nerve.
Because of limited autopsy material, little is presently known about the underlying cochlear pathology of congenital CMV-induced SNHL. Nevertheless, what is known about the histopathology is quite instructive: degeneration or loss at birth of inner and outer hair cells, Reissner's membrane abnormalities, stria vascularis dysplasia, and labyrinthitis (Myers and Stool, 1968; Davis and Hawrisiak, 1977; Stagno et al., 1977; Davis, 1979; Davis, 1981; Strauss, 1990; Rarey and Davis, 1993; Schuknecht, 1993; Teissier et al., 2011) . Further, viral inclusion bodies are found in the organ of Corti, Reissner's membrane, stria vascularis, and lining of the endolabyrinth (Myers and Stool, 1968; Davis, 1981; Teissier et al., 2011) ; viral antigens are immunodetected in the organ of Corti, Reissner's membrane, stria vascularis, and spiral ganglia (Stagno et al., 1977; Teissier et al., 2011) . All this notwithstanding, the paucity of temporal bone autopsy specimens from infants with congenital CMV infection has hindered the critical correlation of pathology with mechanisms of CMVinduced SNHL (Davis, 1981; Strauss, 1990; Fowler and Boppana, 2006) . Thus, there is a clear need for good animal models to investigate the histologic and molecular pathogenesis of CMV-induced SNHL.
Strict species-specificity of human CMV (hCMV) and the inability of species-specific rodent CMV to cross the placenta of mice and rats have hindered productive study of this virus in small animal models (Kern, 2006; Pass et al., 2006; Pass, 2007) . To bypass the need for transplacental transmission of mouse CMV (mCMV), the mCMV has been directly injected into the fetus at midgestation or into the endometrial lumen of pregnant mice at the time of embryo implantation, respectively (Baskar et al., 1983; Baskar et al., 1987; Baskar et al., 1993 ; Tsut- (A-C) In controls, the cochlear duct within the cartilaginous otic capsule (COC) is separated into scala vestibuli (SV), scala media (SM), and scala tympani (ST), each exhibiting distinct lumina. The organ of Corti (OC, black bracket) displays sensory (hair) (double arrows) and nonsensory (supporting) epithelial cells. Higher magnification (C) of organ of Corti showing the single inner hair cell (I) separated from the three outer hair cells (123) by the tunnel of Corti (t). Rm, Reissner's membrane; sv, stria vascularis; T, tectorial membrane. (D-F) The mCMV-infected cochleas are severely dysmorphic, exhibiting abnormal sensory (hair) (triple arrows) and nonsensory epithelia, Reissner's membrane (double arrowheads), and stria vascularis. Clusters of cytomegalic, basophilic, and pleiomorphic infected and affected cells are seen in Reissner's membrane (double arrowheads) and stria vascularis, as well as throughout the ST (E,*) and SV. Pathognomonic kidney shaped nuclei are seen in cells of Reissner's membrane (F, arrowhead), stria vascularis (E, right inset), and in mesenchymal cells found throughout SV and ST (E, left inset; sui, 1995; Li and Tsutsui, 2000; Tsutsui et al., 2005) . Although congenital embryonic abnormalities were reported, the high degree of fetal loss and difficulty in conducting these experiments limits the use of these in vivo mouse models for cell and molecular studies. Evidently, although the guinea pig (gp) is a well-studied model of transplacental viral transmission (Woolf, 1991; Kern, 2006; Schleiss and Choo, 2006; Schleiss, 2006 Schleiss, , 2008 , its use has been limited because of significant differences between human in utero CMV infection and the gpCMV congenital infection model, as well as differences between hCMV and gpCMV biologic characteristics (Kern, 2006; Schleiss and Choo, 2006; Pass, 2007) . Clearly, alternative animal models are needed to delineate the cell and molecular mechanisms underlying CMV-induced cochlear pathogenesis.
A useful and relevant animal model has always to be informed by two key clinical observations: (1) in utero CMV infection causes SNHL, whereas postnatally acquired infection in premature infants does not (Vollmer et al., 2004) ; (2) SNHL is more common in infants with congenital CMV infection resulting from first trimester maternal infection than when infection takes place later in pregnancy (Pass et al., 2006; Foulon et al., 2008a; Foulon et al., 2008b) . Both of these findings highlight the need to investigate the mechanisms of CMV-induced cochlear pathogenesis in embryonic organs. To this end, we have developed an in vitro embryonic mouse model of CMV-induced pathogenesis that mimics the known human pathology, including dysplasia of the organ of Corti, Reissner's membrane, and stria vascularis. This model will prove useful in studying the CMV-induced dysregulation of signaling pathways during early and late stages of cochlear morphogenesis.
MATERIALS AND METHODS Animals
Timed pregnant inbred C57/BL6 female mice were purchased from Charles River (Wilmington, MA; plug day 5 day 0 of gestation) and embryonic day 15 (E15) fetuses were harvested as previously described (Melnick et al., 2006) . All protocols involving mice were approved by the Institutional Animal Care and Use Committee (USC, Los Angeles, CA).
Organ Culture
Whole inner ears were dissected of E15 mouse fetuses and the ventral cochlear region and dorsal vestibular region were separated. Cochleas were cultured using a modified otic organ culture system first described by Van de Water and Ruben (1971) and chemically defined BGJb medium (Invitrogen Corporation, Carlsbad, CA) supplemented with 10% fetal calf serum, 0.5 mg ascorbic acid/ mL, and 50 units/mL penicillin/streptomycin (Invitrogen Corporation), pH 7.2, as previously described (Melnick et al., 2006) . We cultured the cochlear duct with surrounding periotic mesenchyme because prior studies have demonstrated cochlear morphogenesis and hair cell differentiation are dependent on a complex series of interactions between otic epithelia and periotic mesenchyme (e.g., Van de Water and Represa, 1991; Doetzlhofer et al., 2004; Xu et al., 2007) and CMV seems to primarily infect embryonic mesenchyme (Melnick et al., 2006; Jaskoll et al., 2008a; Jaskoll et al., 2008b) . For mCMV infection, cochleas were incubated with 1 3 10 -5 plaque-forming units (PFU)/mL of lacZ-tagged mCMV RM4271 in BGJb on day 0 for 24 hours and then cultured in virus-free media; controls consisted of cochleas cultured in control medium for the entire period. Cochleas were collected and processed for hematoxylin and eosin histology, quantitative RT-PCR (qRT-PCR), immunolocalization, or cell proliferation (proliferating cell nuclear antigen [PCNA] ) analysis. For qRT-PCR, four to five cochleas were pooled, snap frozen, and stored at 2808C. For histology, immunolocalization, and PCNA analyses, cochleas were fixed for 4 hours in Carnoy's fixative or overnight in 4% paraformaldehyde at 48C, embedded in paraffin, serially sectioned at 8 lm, and stained as previously described (Melnick et al., 2006) . For b-galactosidase staining, cochleas were fixed in 0.2% gluteraldehyde, stained, and processed, as previously described (Melnick et al., 2006) . For semi-thin sections, E15 1 12 cochleas were fixed overnight in 10% neutral buffered formalin at 48C, embedded in JB-4 resin according to the JB-4 embedding kit (Polysciences, Inc, Warrington, PA), sectioned at 1 lm, and stained with 1% toluidine blue.
mCMV Distribution
We assayed b-galactosidase (lacZ) activity and localization of viral immediate early (IE1) proteins, as described in Melnick et al. (2006) . For b-galactosidase staining: briefly, mCMV-infected E15 1 6, E15 1 9, and E15 1 12 cochleas were processed, stained for 4 to 6 hours, and photographed. Whole mounts were then dehydrated through graded alcohols, embedded in paraffin, serially sectioned at 8 lm, and counterstained with eosin. For IE1 distribution: mCMV-infected E15 1 6, E15 1 9, and E15 1 12 cochleas were embedded in low melting point paraplast, serially sectioned, and incubated overnight with antimouse IE1 antibodies (kindly provided by Dr. Edward Mocarski, Emory University); controls consisted of sections incubated in the absence of primary antibody. For each experimental protocol, a minimum of three to five explants/day were analyzed.
Immunolocalization
Cultured cochleas were embedded in low melting point paraplast, serially sectioned, and immunostained essentially as described in Melnick et al. (2006 and using the following commercially available antibodies: myosin-VI (Proteus Biosciences, Inc, Ramona, CA; cat. #25-6791); myosin-VIIa (Proteus Biosciences, cat. #25-6790); and KCNQ1 (Santa Cruz Biotechnology, Santa Cruz, CA; cat. #sc-20816). Nuclei were counterstained with DAPI (Invitrogen Corporation). Negative controls were performed in parallel under identical conditions and consisted of sections incubated without primary antibodies. For each treatment group, three to five explants per day per antibody were analyzed. All images in this study were acquired with a Zeiss Axioplan microscope (Carl Zeiss Group, Oberkochen, Germany) equipped with a SPOT RT3 camera and processed with SPOT Advanced (Spot Imaging Solutions, Sterling Heights, MI) and Adobe Photoshop CS2 software (Adobe Systems Incorporated, San Jose, CA).
Cell-specific Distribution of PCNA
The cell-specific localization of PCNA was determined using the Zymed mouse PCNA kit (Invitrogen Corporation) and counterstained with hematoxylin, as previously described (Melnick et al., 2006) ; the cytoplasm stains blue and PCNA-positive nuclei stains dark brown. In this set of experiments, three to eight cultures per treatment per day were analyzed.
PCNA immunolocalization is frequently used as a surrogate marker of cell division (e.g., Chen and Segil, 1999; Melnick et al., 2006; Melnick et al., 2011; von Bohlen und Halbach, 2011) , notably because it is the ''maestro'' of the DNA replication fork (Moldovan et al., 2007) . High fidelity genome duplication is assured through a collection of dynamic PCNA-containing protein complexes at the fork (Kirchmaier, 2011) . During DNA replication, PCNA is loaded onto DNA at the 3 0 ends of primer-template junctions and acts as a sliding clamp that interacts with and enhances the efficiency of the DNA polymerases on the leading and lagging DNA strands (Kirchmaier, 2011) . Thus, because PCNA is central to successful DNA replication, PCNA is a well-recognized surrogate cell division marker (von Bohlen und Halbach, 2011) . Although the sensitivity of this immunoassay approaches 100%, the specificity may be variably reduced because PCNA is also essential for DNA repair and its relatively long halflife (8-20 hours) results in some presence in early G o (Zacchetti et al., 2003) . This may result in an overestimation of the fraction of cells actually dividing.
Quantitative RT-PCR
For analysis of gene expression, qRT-PCR was conducted, as previously described (Melnick et al., 2006; Melnick et al., 2009) , on E15 1 6, E15 1 9, and E15 1 12 control, and mCMV-infected samples; each sample consisted of four to five pooled explants. RNA was extracted and 1 lg RNA was reverse transcribed into first strand cDNA using ReactionReady First Strand cDNA Synthesis Kit: C-01 for reverse transcription (SABiosciences, Frederick, MD). The primer sets used were prevalidated to give single amplicons and purchased from SABiosciences: Kcnq1 (PPM04198A); p19 (Cdkn2d; cat. #PPM02987A); p21 (Cdkn1a; cat. #PPM02901A); p27 (Cdkn1b; cat. #PPM02909A); and Pcna (cat. #PPM03456A). Primers were used at concentration of 0.4 microM. The cycling parameters were 958C, 15 minutes; 40 cycles of (958C, 15 seconds; 558C, 30-40 seconds and 728C, 30 seconds). Specificity of the reactions was determined by subsequent melting curve analysis. RT-PCRs of RNA (not reverse transcribed) were used as negative controls. GAPDH was used to control for equal cDNA inputs and the levels of PCR product were expressed as a function of GAPDH. The relative fold changes of gene expression between the gene of interest and GAPDH, or between the E15 1 6, E15 1 9, and E15 1 12 control and mCMVinfected samples, were calculated by the 2 -DDCT method. Significant expression differences between mCMVinfected and control samples were determined by t test, with a 5 0.01 and the null hypothesis of R 5 1, where R is the mean relative expression ration (mCMV/control) across the entire sample (n 5 9). Expression ratios were log transformed before analysis to satisfy the assumption of normality.
RESULTS
mCMV, having many features in common with hCMV, has been widely used for studying the postnatal pathogenesis associated with acute, latent, and recurrent infections (Krmpotic et al., 2003; Cheeran et al., 2009) ; the mouse is the most comprehensive model system for the developing mammalian cochlea (Kelley, 2007; Driver and Kelley, 2009; Puligilla and Kelley, 2009 ). Here, we developed an embryonic mouse organ culture model to study the effect of mCMV on embryonic cochlear development. Specifically, we infected E15 cochleas with lacZ-tagged mCMV for up to 12 days in vitro, as previously described (Melnick et al., 2006; Jaskoll et al., 2008a; Jaskoll et al., 2008b ) using a modified Van de Water and Ruben (1971) organ culture system; controls were cultured in virus-free, chemically defined media. mCMVinfected cochleas are developmentally delayed and exhibit severely abnormal phenotypes (Figs. 1-5) .
In controls, cochlear morphogenesis and histodifferentation progresses normally in vitro (Fig. 1A-C) . The cochlear duct is separated into the SV, SM, and ST; the organ of Corti, located on the floor of the SM, is characterized by differentiating epithelial sensory hair cells and nonsensory supporting cells (Fig. 1B, C) . Differentiating hair cells can be identified based on position, an increase in nuclei size, a more luminal position of their nuclei, and expression of myosin VI and VIIa, cytoplasmic hair cell-specific markers (Hasson et al., 1995; Hasson et al., 1997) . In controls, the organ of Corti displays three outer hair cells and one inner hair cell (Figs. 1B, C; and 2A) . mCMV infection of E15 cochleas induces a severely dysmorphic and dysplastic phenotype in the organ of Corti, Reissner's membrane, stria vascularis, ST, and SV ( Fig. 1D-F) . Cytomegalic, basophilic, and pleomorphic cells (some with viral inclusion bodies) are found in Reissner's membrane and stria vascularis (Fig. 1E, F) . The sensory (hair) and nonsensory (supporting) epithelial cells of the organ of Corti are severely disorganized (Fig.  1E, F) ; significantly, mCMV seems to induce a hair cell hyperplasia that is densely packed and misaligned (Fig. 2B) . mCMV infection also induces substantial differences in the periotic mesenchyme that surrounds the forming ST and SV, namely the presence of basophilic, cytomegalic cells (Fig. 1E, F) . Coincident with the presence of pathognomonic kidney shaped nuclei (Fig. 1E  insets, F) , lac-Z-tagged mCMV (Fig. 3A) , and viral IE1 (immediate early 1) protein (Fig. 3B ) are clearly evident in Reissner's membrane, stria vascularis, ST, and SV, and less so in the organ of Corti. Finally, it should be noted that near simultaneous administration of the antiherpes viral nucleoside, acyclovir, with mCMV infection obviates all cochlear abnormality (data not shown), as is the case with other developing organs previously studied (Melnick et al., 2006; Jaskoll et al., 2008a; Jaskoll et al., 2008b; Melnick et al., 2011) .
Dysregulation of the Cell Cycle
Given that (1) mCMV infection has repeatedly been shown to induce cell proliferation and to concomitantly dysregulate the gene and protein expression of numerous components of the cell cycle (Hertel and Mocarski, 2004; Melnick et al., 2006; Hertel et al., 2007; Melnick et al., 2011) , and (2) withdrawal from the cell cycle is a prerequisite of organ of Corti histodifferentation (Ruben, 1967; Chen and Segil, 1999; Laine et al., 2007) , we compared the cell-specific distribution of PCNA, an E2F/DP target gene during the S-phase of active cell division (Chen and Segil, 1999; Melnick et al., 2006) , in infected and uninfected E15 cochleas cultured for 6 (E15 1 6), 9 (E15 1 9), and 12 (E15 1 12) days (Fig. 4) . A dramatic increase in PCNA-positive nuclei is seen in mCMVinfected and affected cochlear mesenchymal and epithelial cells, including apparent nonsensory, supporting epithelial cells of the organ of Corti (compare Fig. 4B , D, F to 4A, B, C); the variability of PCNA expression is time dependent (compare Fig. 4B, D, and F) . The results are consistent with the evolving hyperplasias and dysplasias noted above (Figs. 1 and 2) .
Cyclin-dependent kinase (Cdkn) inhibitors are critical gatekeepers of S-phase entry in the cell cycle; they bind to and inhibit cyclin-dependent kinase/cyclin complexes, and thus inhibit cell proliferation. Inhibitors p19 (Cdkn2d) and p21 (Cdkn1a) and inhibitor p27 (Cdkn1b) serve to regulate the number of hair cells and supporting cells, respectively (Chen and Segil, 1999; Laine et al., 2007) . The qRT-PCR reveals the time-dependent changes in p19, p21, and p27 gene expression relative to Pcna gene expression (Table 1) . At E15 1 6, there is a highly significant (p < 0.001) drop in p19 and p27 expression but a near 50% increase in p21 (p < 0.01); there is a modest but significant (p < 0.001) increase in Pcna. Although p19 and p27 expression rebounds across postinfection days 9 and 12, there remains a highly significant (p < 0.001) 2.5 to 3-fold increase in Pcna expression; this is consistent with the common lag between gene transcription and protein translation. The correlation and timing of Cdkn downregulation and Pcna upregulation with upregulation of PCNA protein informs the mechanism of cochlear hyperplasia.
Stria Vascularis Dysplasia
The stria vascularis is composed of three cell layers (Kikuchi and Hilding, 1966; Jin et al., 2007) . The marginal cells face the lumen of the SM and are characterized by numerous mitochondria and extensive membrane infolding; the intermediate cells are neural crest-derived melanocytes; the basal cells are characterized by tight junctions and serve as a barrier between the stria vascularis and the adjacent spiral ligament. The stria vascularis of mCMV-infected E15 1 12 cochleas are severely dysplastic (Figs. 1 and 5) . The cells of all three layers are greatly enlarged and misaligned, making clear distinction of the layers difficult. With mCMV infection, many of the cytomegalic cells contain pathognomonic kidney shaped nuclei (Fig. 5B ) and viral IE1 protein (Fig. 5B, left inset) ; the melanocytes are reduced in number and dysmorphic Figure 4 . Mouse cytomegalovirus (mCMV) induces a notable increase in proliferating cell nuclear antigen (PCNA)-positive nuclei in mCMV-infected cochleas on days 6, 9, and 12 of culture. In embryonic day 15 (E15) 1 6 (A), E15 1 9 (C), and 15 1 12 (E) controls, PCNA-positive nuclei (brown) are relatively absent. Note the absence of PCNA-positive nuclei in the single inner hair cell (I), the three outer hair cells (123) and epithelial nonsensory supporting cells. In contrast, mCMV-infected E15 1 6 (B), E15 1 9 (D), and E15 1 12 (F) cochleas exhibit a dramatic increase in PCNA-positive nuclei in infected and affected cells. In E15 1 6 cochleas, PCNA-positive nuclei are seen in the relatively normal appearing single inner hair and three outer hair cells (double arrows), as well as throughout cochlear epithelia, stria vascularis (sv), Reissner's membrane (arrowhead), and abnormal periotic mesenchyme. By days 9 (E15 1 9) (D) and 12 (E15 1 12) (E) of culture, the mCMV-infected cochleas seem more severely abnormal. On day 9 (D), PCNA-positive nuclei are found in the hair cells (triple arrows) of the dysmorphic organ of Corti, Reissner's membrane (arrowhead), the stria vascularis (sv), spiral ligament, and in the cytomegalic, basophilic mesenchymal cells (m) found throughout the scala vestibuli (SV) and scala tympani (ST). On day 12 (F), PCNA-positive nuclei are primarily seen in the stria vascularis and are mostly absent from the cochlear epithelial cells. Bar: (A-D)-30 lm; (E, F)-50 lm.
( Fig. 5B, right inset) . Finally, there is a marked downregulation of potassium channel KCNQ1 protein in the marginal cells of the mCMV-infected stria vascularis (compare Fig. 5D to C). This is concomitant with a highly significant (p < 0.001) and dramatic 60 to 75% decline in Kcnq1 gene expression across all days of infection (Table 1) .
DISCUSSION
As noted above, congenital hCMV infection is the leading nongenetic etiology of SNHL at birth and prelingual SNHL not expressed at birth Nance et al., 2006; Grosse et al., 2008) . Limited human temporal bone autopsy investigation reveals an instructive correlation of pathognomonic kidney shaped nuclei and viral antigens in the organ of Corti, Reissner's membrane, and stria vascularis, with aplasia/hyperplasia of hair cells, as well as dysplasia of Reissner's membrane and stria vascularis (Myers and Stool, 1968; Davis and Hawrisiak, 1977; Stagno et al., 1977; Davis, 1979; Davis, 1981; Strauss, 1990; Rarey and Davis, 1993; Schuknecht, 1993; Teissier et al., 2011) . Here, we present an in vitro embryonic mouse model of CMVinfected cochleas that mimics the human sites of viral infection and associated pathology (Figs. 1-5) . Further, it provides initial insight into the likely cell and molecular pathogenesis of the resultant hearing loss (Figs. 4 and 5; Table 1 ).
In general, mCMV infection induces a severely dysmorphic embryonic cochlear phenotype, including hyperplasia and dysplasia in the organ of Corti, Reissner's membrane, stria vascularis, SV, and ST. Several findings are of particular note: hyperplasia of hair cells; downregulation of KCNQ1 protein expression in the stria vascularis; hypoplastic and dysmorphic melanocytes.
Organs of Corti in mCMV-infected cochleas are characterized by hyperplasia and malalignment of sensory (hair) and nonsensory (supporting) epithelium (Figs. 1 and 2 ). The organ of Corti develops from a subset of epithelial cells occupying the floor of the cochlear duct; by E14.5, this prosensory domain becomes totally postmitotic and terminal histodifferentiation commences; by E17, differentiated hair cells and supporting cells have arranged themselves into a nectin-dependent checkerboard-like pattern along the entire length of the cochlear duct (Kelley, 2007; Togashi et al., 2011) . Withdrawal from the cell cycle is critical to the proper histodifferentation; maintaining withdrawal is critical to the morphologic and functional integrity of the organ of Corti (Ruben, 1967) . Important to this cell cycle inhibition are the cyclin-dependent kinase inhibitors p19, p21, and p27 (Chen and Segil, 1999; Chen et al., 2003; Laine et al., 2007) .
The embryonic organ culture model shows a dramatic increase in immunolocalized PCNA, a surrogate S-phase marker of cell division, in mCMV-infected cochlear epithelium and mesenchyme, including the cells in the organ of Corti (Fig. 4) . This is concomitant with significant changes in p19, p21, p27, and Pcna gene expression ( Table 1) . Inter alia, downregulation of cdk-inhibitors results in S-phase entry, upregulation of Pcna expression, and increased cell division. The patterns of expression through in vitro stages equivalent to perinatal (E15 1 6) and early postnatal (E15 1 9, E15 1 12) cochlear development are instructive: p19 and p27 are dramatically lower at E15 1 6, less so at E15 1 9, and normal or elevated at E15 1 12; p21 is significantly elevated at E15 1 6 and E15 1 9, but returns to normal with the recovery of p19 and p27 at E15 1 12; Pcna transcript is significantly elevated throughout.
Although p21 has been shown to compensate for p19 deletion (Laine et al., 2007) , upregulation of p21 seems to have little effect upon the delayed withdrawal from or re-entry to the cell cycle of cells in the prosensory domain well into the modeled early postnatal period. Still, the fact that by E15 1 12 all three cdk-inhibitors are at or above control levels suggests that the prosensory epithelium is about to withdraw from the cell cycle shortly. Finally, it is clear that by E15 1 12 there is a well-defined population of excessive and disorganized hair cells (Figs. 1F and 2B) . What is not clear is whether these cells result from continued proliferation of sensory epithelium or transdifferentiation from proliferating nonsensory epithelium or both. Also not known is whether the apparent increased number of hair cells is transient and will succumb to subsequent p53-mediated apoptosis as seen with p19 and p21 deletions (Chen et al., 2003; Laine et al., 2007) . What is certain is that malalignment or loss of sensory hair cells is not compatible with normal hearing.
The stria vascularis of mCMV-infected cochleas are severely dysplastic, so much so that its trilaminar structure is not discernible (Fig. 5B) . Concomitant is a 60 to 75% decline in Kcnq1 message (Table 1) and sparse protein localization on the luminal surface of the marginal cells (Fig. 5D ). KCNQ1 is a K 1 ion channel protein that is critical to normal endolymph production and, thus, the integrity of endolymphatic spaces in the cochlea. Loss of functional KCNQ1 K 1 channels results in human and mouse deafness associated with compromised production of endolymph, including the eventual contraction of the SM, collapse of Reissner's membrane, atrophy of the stria vascularis, and degeneration of the organ of Corti and spiral ganglion (Casimiro et al., 2001; Rivas and Francis, 2005) .
The stria vascularis of mCMV-infected cochleas is also characterized by dysmorphic and insufficient numbers of melanocytes (Fig. 5B) . Intermediate layer melanocytes are essential for normal hearing and melanocyte abnormality results in hearing loss (Schrott and Spoendlin, 1987; Steel and Barkway, 1989; Cable et al., 1992; Peters et al., 1995;  Tachibana, 1999; Uehara et al., 2009) . The cell and molecular functions of cochlear melanocytes is not certain. What is known is that melanocytes are required for normal stria vascularis development and function, including mediating the organizational relationship of marginal and basal cells in the trilaminal stria structure, and ion regulation and transport (Steel and Barkway, 1989; Cable et al., 1992; Tachibana, 1999; Bush and Simon, 2007) .
To summarize, we describe an in vitro embryonic mouse model of CMV-induced cochlear pathogenesis that mimics the known human pathology. There are several key abnormalities, any one of which would result in deafness at birth or shortly thereafter, including hyperplasia and disorganization of hair and supporting cells in the organ of Corti, as well as stria vascularis dysplasia with concomitant KCNQ1 downregulation and melanocyte hypoplasia and dysmorphia. This is consistent with the emerging understanding that viruses intrinsically depend on their host cells to replicate, assemble, and propagate, they elicit cell and molecular pathologic phenotypes similar to those arising from known gene mutations (Gulbahce et al., 2012; Rozenblatt-Rosen et al., 2012) . Thus, the model presented here provides a relevant and reliable platform within which the detailed cell and molecular biology of CMV-induced deafness may be studied.
